Reprogramming of liver cells into insulin-producing cells

Best Pract Res Clin Endocrinol Metab. 2015 Dec;29(6):873-82. doi: 10.1016/j.beem.2015.10.006. Epub 2015 Oct 8.

Abstract

Tissue replacement is a promising direction for the treatment of diabetes, which will become widely available only when islets or insulin-producing cells that will not be rejected by the diabetic recipients are available in unlimited amounts. The present review addresses the research in the field of generating functional insulin-producing cells by transdifferentiation of adult liver cells both in vitro and in vivo. It presents recent knowledge of the mechanisms which underlie the process and assesses the challenges which should be addressed for its efficient implementation as a cell based replacement therapy for diabetics.

Keywords: diabetes; liver; pancreatic transcription factors; reprogramming; transdifferentiation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Transdifferentiation*
  • Hepatocytes / cytology*
  • Hepatocytes / metabolism
  • Humans
  • Insulin-Secreting Cells / cytology*
  • Insulin-Secreting Cells / metabolism
  • Insulin-Secreting Cells / transplantation
  • Liver Regeneration*